本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioNexus Gene Lab Corp.

1.61
+0.13008.78%
盤後1.610.00000.00%16:04 EDT
成交量:1,826
成交額:2,898
市值:472.28萬
市盈率:-1.29
高:1.61
開:1.54
低:1.54
收:1.48
52周最高:6.10
52周最低:1.07
股本:293.34萬
流通股本:188.10萬
量比:0.32
換手率:0.10%
股息:- -
股息率:- -
每股收益(TTM):-1.2467
每股收益(LYR):-1.6075
淨資產收益率:-33.66%
總資產收益率:-18.99%
市淨率:0.61
市盈率(LYR):-1.00

資料載入中...

2023/10/16

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/07

重要事件披露

Form 8-K - Current report
2023/08/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/20

重要事件披露

Form 8-K - Current report
2023/07/17

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/15

重要事件披露

8-K - Current report
2022/08/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/06

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/11/09

[修訂]季度報告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2020/11/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/08

重要事件披露

8-K - Current report